Scalable Synthesis of l-allo-Enduracididine: The Unusual Amino Acid Present in Teixobactin

Namdeo Gangathade; Kiranmai Nayani; Hemalatha Bukya; Prathama S. Mainkar; Srivari Chandrasekhar

doi:10.1055/a-1528-0625

Synlett, Inhaltsverzeichnis

Synlett 2021; 32(14): 1465-1468
DOI: 10.1055/a-1528-0625

letter

Scalable Synthesis of l-allo-Enduracididine: The Unusual Amino Acid Present in Teixobactin

Autor*innen

Namdeo Gangathade

^aDepartment of Organic Synthesis and Process Chemistry, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad 50007, India

^bAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India
Kiranmai Nayani

^aDepartment of Organic Synthesis and Process Chemistry, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad 50007, India
Hemalatha Bukya

^aDepartment of Organic Synthesis and Process Chemistry, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad 50007, India

^bAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India
Prathama S. Mainkar

^aDepartment of Organic Synthesis and Process Chemistry, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad 50007, India

^bAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India
Srivari Chandrasekhar ∗

^aDepartment of Organic Synthesis and Process Chemistry, CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad 50007, India

^bAcademy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India

Abstract

Alle Artikel dieser Rubrik

Abstract

A scalable synthesis of l-allo-enduracididine is achieved from commercially available (S)-glycidol in ten linear steps involving well-established synthetic transformations. The synthetic route is flexible and can be used to synthesize all four diastereomers by changing the stereochemistry of glycidol and Sharpless asymmetric dihydroxylation reagent.

Key words

antibiotics - teixobactin - depsipeptide - unusual amino acid - l-allo-enduracididine - Staudinger reaction - Sharpless asymmetric dihydroxylation

Volltext

Referenzen

References and Notes

1a Willyard C. Nature 2017; 543: 7643
1b Arias CA, Murray BE. N. Engl. J. Med. 2015; 372: 1168
1c Zhen X, Lundborg CS, Sun X, Hu X, Dong H. Antimicrob. Resist. Infect. Control 2019; 8: 137
1d Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. Front. Microbiol. 2019; 10: 539

2 Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, Mueller A, Schaeberle TF, Hughes DE, Epstein S, Jones M, Lazarides L, Steadman VA, Cohen DR, Felix CR, Fetterman KA, Millett WP, Nitti AG, Zullo AM, Chen C, Lewis K. Nature 2015; 517: 455
3 Ng V, Chan WC. Chem. Eur. J. 2016; 22: 12606
4 Atkinson DJ, Naysmith BJ, Furkert DP, Brimble MA. Beilstein J. Org. Chem. 2016; 12: 2325
5 Giltrap AM, Dowman LJ, Nagalingam G, Ochoa JL, Linington RG, Britton WJ, Payne RJ. Org. Lett. 2016; 18: 2788
6 Jin K, Sam LH, Po KH. L, Lin D, Zadeh EH. G, Chen S, Yuan Y, Li X. Nat. Commun. 2016; 7: 12394
7 Liu L, Wu S, Wang Q, Zhang M, Wang B, He G, Chen G. Org. Chem. Front. 2018; 5: 1431
8 Gao B, Chen S, Hou YN, Zhao YJ, Ye T, Xu Z. Org. Biomol. Chem. 2019; 17: 1141
9 Zong Y, Fang F, Meyer KJ, Wang L, Ni Z, Gao H, Lewis K, Zhang J, Rao Y. Nat. Commun. 2019; 10: 3268

10a Jad YE, Acosta GA, Naicker T, Ramtahal M, El-Faham A, Govender T, De la Torre BG, Albericio F. Org. Lett. 2015; 17: 6182
10b Parmar A, Iyer A, Vincent CS, Van Lysebetten D, Prior SH, Madder A, Taylor EJ, Singh I. Chem. Commun. 2016; 52: 6060
10c Yang H, Chen KH, Nowick JS. ACS Chem. Biol. 2016; 11: 1823
10d Monaim SA. H. A, Jad YE, Acosta GA, Naicker T, Ramchuran EJ, El-Faham A, Govender T, Kruger HG, De la Torre BG, Albericio F. RSC Adv. 2016; 6: 73827
10e Monaim SA. H. A, Jad YE, Ramchuran EJ, El-Faham A, Govender T, Kruger HG, De la Torre BG, Albericio F. ACS Omega 2016; 1: 1262
10f Monaim SA. H. A, Noki S, Ramchuran EJ, El-Faham A, Albericio F, De la Torre BG. Molecules 2017; 22: 1632
10g Monaim SA. H. A, Ramchuran EJ, El-Faham A, Albericio F, De la Torre BG. J. Med. Chem. 2017; 60: 7476
10h Wu C, Pan Z, Yao G, Wang W, Fang L, Su W. RSC Adv. 2017; 7: 1923
10i Jin K, Po KH. L, Wang S, Reuven JA, Wai CN, Lau HT, Chan TH, Chen S, Li X. Bioorg. Med. Chem. 2017; 25: 4990
10j Parmar A, Iyer A, Lloyd DG, Vincent CS, Prior SH, Madder A, Taylor EJ, Singh I. Chem. Commun. 2017; 53: 7788
10k Parmar A, Iyer A, Prior SH, Lloyd DG, Goh ET. L, Vincent CS, Pallag TP, Bachrati CZ, Breukink E, Madder A, Lakshminarayanan R, Taylor EJ, Singh I. Chem. Sci. 2017; 8: 8183
10l Schumacher CE, Harris PW. R, Ding X.-B, Krause B, Wright TH, Cook GM, Furkert DP, Brimble MA. Org. Biomol. Chem. 2017; 15: 8755
10m Ng V, Kuehne SA, Chan WC. Chem. Eur. J. 2018; 24: 9136
10n Parmar A, Lakshminarayanan R, Iyer A, Mayandi V, Goh ET. L, Lloyd DG, Chalasani ML. S, Verma NK, Prior SH, Beuerman RW, Madder A, Taylor EJ, Singh I. J. Med. Chem. 2018; 61: 2009

11a Parmar A, Prior SH, Iyer A, Vincent CS, Van Lysebetten D, Breukink E, Madder A, Taylor EJ, Singh I. Chem. Commun. 2017; 53: 2016
11b Yang H, Du Bois DR, Ziller JW, Nowick JS. Chem. Commun. 2017; 53: 2772
11c Chen KH, Le SP, Han X, Frias JM, Nowick JS. Chem. Commun. 2017; 53: 11357
11d Yang H, Wierzbicki M, Du Bois DR, Nowick JS. J. Am. Chem. Soc. 2018; 140: 14028
11e Monaim SA. H. A, Jad YE, El-Faham A, De la Torre BG, Albericio F. Bioorg. Med. Chem. 2018; 26: 2788
11f Yang H, Pishenko AV, Li X, Nowick JS. J. Org. Chem. 2020; 85: 1331
11g Gunjal VB, Thakare R, Chopra S, Reddy DS. J. Med. Chem. 2020; 63: 12171

12 Dhara S, Gunjal VB, Handore KL, Reddy DS. Eur. J. Org. Chem. 2016; 4289

13a Rudolph J, Hannig F, Theis H, Wischnat R. Org. Lett. 2001; 3: 3153
13b Peoples AJ, Hughes D, Ling LL, Millett W, Nitti A, Spoering A, Steadman VA, Chiva JY. C, Lazarides L, Jones MK, Poullence KG, Lewis K. WO2014089053 2014
13c Peoples, A. J.; Hughes, D.; Ling, L. L.; Millett, W.; Nitti, A.; Spoering, A.; Steadman, V. A.; Chiva, J. Y. C.; Lazarides, L.; Jones, M. K.; Poullence, K. G.; Lewis, K. US20140194345, 2014.

14 Craig W, Chen J, Richardson D, Thorpe R, Yuan Y. Org. Lett. 2015; 17: 4620

15a Sangeetha D, Nayani K, Mainkar PS, Chandrasekhar S. Synlett 2019; 30: 2268
15b Bukya H, Nayani K, Gangireddy P, Mainkar PS. Eur. J. Org. Chem. 2020; 5358

16 Carneiro VM. T, Avila CM, Balunas MJ, Gerwick WH, Pilli RA. J. Org. Chem. 2014; 79: 630
17 Bonini C, Chiummiento L, Lopardo MT, Pullez M, Colobert F, Solladie G. Tetrahedron Lett. 2003; 44: 2695

18a Sharpless KB, Amberg W, Bennani YL, Crispino GA, Hartung J, Jeong KS, Kwong HL, Morikawa K, Wang ZM, Xu D, Zhang X.-L. J. Org. Chem. 1992; 57: 2768
18b Kolb HC, Sharpless KB. Chem Rev. 1994; 94: 2483

19a Austad BA, Calkins TL, Fang FG, Horstmann TE, Hu Y, Lewis BM, Niu X, Noland TA, Orr JD, Schnaderbeck MJ, Zhang H, Asakawa N, Asai N, Chiba H, Hasebe T, Hoshino Y, Ishizuka H, Kajima T, Kayano A, Komatsu Y, Kubota M, Kuroda H, Miyazawa M, Tagami K, Watanabe T. Synlett 2013; 24: 333
19b Sun D.-Y, Han G.-Y, Gong J.-X, Nay B, Li X.-W, Guo Y.-W. Org. Lett. 2017; 19: 714

20 Synthetic Procedure for Guanidine Derivative 3 Triphenylphosphine (2.0 g, 7.2 mmol) was added to a stirred solution of azide 8 (1.27 g, 2.5 mmol) in THF–H₂O (15 mL, 3:1) at 0 °C. Then the reaction was allowed to warm to room temperature and stirred for 12 h. After this period, to the reaction Goodman’s reagent (N,N'-di-Cbz-1H-pyrazole-1-carboxamidine, 968 mg, 2.5 mmol) was added, and the mixture was stirred for another 6 h. The reaction was extracted with EtOAc (2 × 100 mL), the organic layer was washed with brine (75 mL), dried over anhydrous Na₂SO₄, and concentrated under vacuum. The residue was purified by column chromatography on silica gel using 85:15 hexanes–EtOAc (v/v) as eluent to give 3 (1.7 g, 85%) as a white solid. TLC: R_f = 0.5 (hexanes–EtOAc, 7:3); mp 92 °C; [α]_D ²⁰ +6.2 (c 1.1, CHCl₃). IR (neat): ν_max = 3370, 3334, 2946, 1640, 1057 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 11.65 (s, 1 H), 8.71–8.68 (br s, 1 H), 7.57–7.50 (m, 4 H), 7.40–7.16 (m, 16 H), 5.10 (s, 2 H), 5.04 (s, 2 H), 4.82 (d, J = 8.8 Hz, 1 H), 4.55 (s, 1 H), 3.86–3.75 (m, 1 H), 3.75–3.59 (m, 3 H), 3.51 (dd, J = 10.3, 3.7 Hz, 1 H), 3.23–3.08 (m, 1 H), 1.65–1.53 (m, 1 H), 1.37 (s, 9 H), 1.35–1.25 (m, 1 H), 0.98 (s, 9 H). ¹³C NMR (101 MHz, CDCl₃): δ = 163.6, 157.3, 156.1, 153.5, 136.7, 135.6, 135.5, 134.6, 132.9, 132.7, 129.9, 129.8, 128.6, 128.5, 128.4, 128.3, 128.1, 127.8, 127.8, 80.1, 68.0, 67.0, 66.3, 48.6, 46.3, 38.1, 28.3, 26.8, 19.2. HRMS (ESI): m/z calcd for [M + H]⁺: C₄₃H₅₅N₄O₈Si: 783.3779; found: 783.3783.
21 Synthetic Procedure for Intramolecular Cyclization of Guanidine Derivative 3; (S)-Benzyl-2-{[(benzyloxy)carbonyl]imino}-5-{(S)-2-[(tert-butoxycarbonyl)amino]-3-[(tert-butyl diphenylsilyl)oxy]propyl}imidazolidine-1-carboxylate (9) To a solution of 3 (3.2 g, 4 mmol) in anhydrous CH₂Cl₂ (20 mL) was added DIPEA (3.6 mL, 20 mmol), followed by Tf₂O (0.76 mL, 4.5 mmol) dropwise at –78 °C under nitrogen atmosphere. After stirring for 1 h, the reaction was quenched by the addition of ammonium chloride (100 mL), the two layers were separated, and the aqueous layer was extracted with CH₂Cl₂ (100 mL). The combined organic layer was washed with brine (50 mL), dried over anhydrous Na₂SO₄, and concentrated under vacuum to give a colorless oil. The residue was purified by column chromatography on silica gel using 70:30 hexanes–EtOAc (v/v) as eluent to give 9 (2.81 g, 90%) as a white solid. TLC: R_f = 0.5 (hexanes–EtOAc, 1:1); mp 84 °C; [α]_D ²⁰ –7.5 (c 1.0, CHCl₃). IR (neat): ν_max = 3758, 3709, 3481, 3367, 2940, 1710, 1259, 1159 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 8.82–8.41 (br s, 1 H), 7.63–7.52 (m, 4 H), 7.47–7.27 (m, 16 H), 5.27 (s, 2 H), 5.16 (q, J = 12.4 Hz, 2 H), 4.63 (d, J = 8.9 Hz, 1 H), 4.34 (t, J = 8.4 Hz, 1 H), 3.79 (t, J = 8.4 Hz, 1 H), 3.72–3.60 (m, 2 H), 3.52 (dd, J = 9.9, 3.4 Hz, 1 H), 3.43 (d, J = 9.5 Hz, 1 H), 2.07 (t, J = 12.0 Hz, 1 H), 1.63 (t, J = 11.8 Hz, 1 H), 1.43 (s, 9 H), 1.01 (s, 9 H). ¹³C NMR (126 MHz, CDCl₃): δ = 156.0, 135.6, 135.6, 135.3, 133.1, 132.9, 130.1, 130.0, 128.8, 128.4, 128.2, 128.0, 127.9, 79.8, 68.4, 67.5, 66.5, 54.0, 48.7, 36.1, 28.5, 26.9, 19.3. HRMS (ESI): m/z calcd for [M + H]⁺: C₄₃H₅₃N₄O₇Si: 765.3662; found: 765.3678.

Zusatzmaterial

Supporting Information (PDF) (opens in new window)